EVP R&D, Chief Medical Officer
Wed, Nov 6, 2024
Nov 6
10,471 shares @ $29.53
Decreased holdings by -9.50%
26th largest trade (out of 157)
Planned (10b5-1)
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
Price 10% above 200-day moving average